WinCo Foods, LLC Products: Over the Counter Medications Section

Page 1 of 23 1 2 3 4 5 … 10 15 20 … » Last Page »

70% Isopropyl Rubbing Alcohol (Isopropyl Rubbing Alcohol)

Helps prevent the risk of infection in: Minor cuts. Scrapes. Burns. Warnings: For external use only. If taken interanlly serious gastic disturbances will result. Flammable Keep away from…

WinCo Foods, LLC18 November 2022

Acetaminophen Easy Tabs Extra Strength (1)

Acetaminophen Easy Tabs Extra Strength (Acetaminophen)

Temporarily relieves minor aches and pains due to: the common cold, headache, backache, minor pain of arthritis, toothache, muscular aches, premenstrual and menstrual cramps, temporarily…

WinCo Foods, LLC31 December 2018

Acetaminophen Extra Strength (Acetaminophen)

Temporarily relieves minor aches and pains due to: the common cold, headache, backache, minor pain of arthritis, toothache, muscular aches, premenstrual and menstrual cramps, temporarily…

WinCo Foods, LLC31 December 2018

Acetaminophen PM Extra Strength (Acetaminophen and Diphenhydramine Hydrochloride)

Temporary relief of occasional headaches and minor aches and pains with accompanying sleeplessness. Warnings: Liver warning: This product contains acetaminophen. Severe liver damage may…

WinCo Foods, LLC31 December 2018

Acetaminophen Regular Strength (Acetaminophen)

Temporarily relieves minor aches and pains due to: the common cold, headache, backache, minor pain of arthritis, toothache, muscular aches, premenstrual and menstrual cramps, temporarily…

WinCo Foods, LLC31 December 2018

Page 1 of 23 1 2 3 4 5 … 10 15 20 … » Last Page »

FDA Medwatch

Antiseizure Medicines Keppra, Keppra XR, Elepsia XR, Spritam (levetiracetam) and Onfi, Sympazan (clobazam): Drug Safety Communication – FDA Warns of Rare but Serious Drug Reaction
Mon, 27 Nov 2023. The FDA is warning that the antiseizure medicines can cause a rare but serious reaction, called Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), that can be life-threatening if not diagnosed and treated quickly.
BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies: FDA Safety Communication – FDA Investigating Serious Risk of T-cell Malignancy
Mon, 27 Nov 2023. The FDA has received reports of T-cell malignancies, including chimeric antigen receptor CAR-positive lymphoma, in patients who received treatment with BCMA- or CD19-directed autologous CAR T cell immunotherapies.

OTCLabels

Medication Sections

Medication Information by RSS

About

Our database comes directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. OTCLabels.com provides the full over the counter products subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.